Skip to main content
U.S. flag

An official website of the United States government

Developing transmissible vaccines for animal infections

April 18, 2024
Many emerging and reemerging pathogens originate from wildlife, but nearly all wild species are unreachable using conventional vaccination, which requires capture of and vaccine administration to individual animals. By enabling immunization at scales sufficient to interrupt pathogen transmission, transmissible vaccines (TVs) that spread themselves through wildlife populations by infectious processes could potentially transform the management of otherwise intractable challenges to public health, wildlife conservation, and animal welfare. However, generating TVs likely requires modifying viruses that would be intended to spread in nature, which raises concerns ranging from technical feasibility, to safety and security risks, to regulatory uncertainties (12). We propose a series of commitments and strategies for vaccine development—beginning with a priori decisions on vaccine design and continuing through to stakeholder codevelopment [see supplementary materials (SM)]—that we believe increase the likelihood that the potential risks of vaccine transmission are outweighed by benefits to conservation, animal welfare, and zoonosis prevention.
Publication Year 2024
Title Developing transmissible vaccines for animal infections
DOI 10.1126/science.adn3231
Authors Daniel G. Streicker, Megan E. Griffiths, Rustom Antia, Laura M. Bergner, Peter Bowman, Maria Vitoria dos Santos de Moraes, Kevin Esvelt, Mike Famulare, Amy T. Gilbert, Biao He, Michael A. Jarvis, David A. Kennedy, Jennifer Kuzma, Carolyne Nasimiyu Wanyonyi, Christopher Remien, Kyle Rosenke, Tonie E. Rocke, Courtney Schreiner, Justin Sheen, David Simons, Ivet A. Yordanova, James J. Bull, Scott L. Nuismer
Publication Type Article
Publication Subtype Journal Article
Series Title Science
Index ID 70253159
Record Source USGS Publications Warehouse
USGS Organization National Wildlife Health Center